Spiral Microfluidic Device for Rapid Pathogen Isolation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current diagnostic methods for infectious diseases, particularly bacterial, fungal, and parasitic infections, are hindered by the slow culture methods, which are inefficient in identifying pathogens and their drug resistance profiles, leading to delayed treatment and increased antibiotic resistance, especially in settings with limited laboratory infrastructure.
Innovation Solution
Development of microfluidic devices with spiral channels that separate microbes from blood samples by exploiting size differences using Dean vortices and inertial lift forces, allowing for efficient isolation of microbes from a vast excess of blood cells, enabling rapid detection and analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If culture methods are used to identify pathogens and their drug resistance profiles, then accurate identification can be achieved, but the process takes several days or more leading to delayed treatment
Solution Approach 1:
The device segments the sample processing into distinct functional zones: inertial separation region for isolating microbes from blood cells, enrichment region for concentrating pathogens, and detection region for rapid identification. This segmentation enables parallel processing of separation and detection functions, reducing total diagnosis time while maintaining accuracy
Solution Approach 2:
The system performs preliminary inertial separation and enrichment of microbes from crude samples before detection. By pre-concentrating pathogens and removing inhibitory blood cells in advance, the system enables rapid downstream molecular detection without requiring lengthy culture steps, achieving both speed and accuracy
2Speed
If PCR-based methods are used for rapid pathogen detection, then detection speed is improved, but sensitivity is reduced in crude samples due to inhibitory effects of bodily fluids
Solution Approach 1:
The device extracts and removes inhibitory components (red blood cells, leukocytes, plasma proteins) from the crude sample through inertial separation. By taking out these interfering elements before PCR detection, the system maintains high detection sensitivity while achieving rapid results from undiluted clinical samples
Solution Approach 2:
The microfluidic inertial separation system acts as an intermediary between sample collection and PCR detection. It preprocesses crude samples by enriching microbes and removing inhibitors, creating an optimized intermediate state that enables both rapid and sensitive molecular detection without requiring sample dilution or extensive preparation
3Productivity
If microfluidic devices with spiral channels are used to separate microbes from blood samples, then separation efficiency is improved, but device complexity increases
Solution Approach 1:
The spiral microchannel design enables self-service separation where the fluid flow itself generates the separating forces through curved geometry. The centrifugal and inertial forces arise automatically from the spiral channel structure and flow dynamics, eliminating the need for external centrifuges, pumps, or complex control systems while achieving high separation efficiency
4Loss of time
If rapid detection methods are implemented, then treatment time is reduced, but the ability to determine drug resistance profiles is limited
Solution Approach 1:
The microfluidic device integrates multiple functions into a single platform: inertial separation of microbes, enrichment of pathogen concentration, and compatibility with various detection methods including PCR and mass spectrometry. This multi-functional design enables both rapid identification and drug resistance profiling from the same processed sample, achieving versatility without sacrificing speed
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The microfluidic devices achieve high recovery efficiency of microbes (>65%) while minimizing contamination from red blood cells and leukocytes, facilitating rapid pathogen detection and antibiotic susceptibility testing, even at low concentrations, and can process high hematocrit samples with reduced preparatory time.
Implementation Method 1
separate microbes from blood samples by exploiting size differences using Dean vortices and inertial lift forces
Implementation Method 2
separate microbes from blood samples by exploiting size differences using Dean vortices and inertial lift forces
Data Source
AI summary
A method and microfluidic device useful for isolating microbes from a blood sample which includes introducing the blood sample into the sample inlet of a spiral microfluidic device; and introducing a second fluid into the sheath inlet of the microfluidic device, wherein the spiral channel terminates in a microbe outlet and a waste outlet, and wherein the spiral channel includes a length, height, and a width that define an aspect ratio adapted to isolate any microbes present in the sample along a first portion of the spiral channel terminating at the microbe outlet, and to isolate red blood cells and leukocytes along a second portion of the spiral channel terminating at the waste outlet; and collecting the microbes from the microbe outlet, thereby isolating the microbes.